Clinical Trial

The Effect of General Anesthesia with Remimazolam and Propofol on Rhythmic State and Cognitive Function

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 14, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study want to observe the effects of remimazolam and propofol for general anesthesia on postoperative rhythm and cognitive function. The observation group was given remimazolam for general anesthesia, and the control group was given propofol for general anesthesia. Both drugs are commonly used as intravenous anesthetics for general anesthesia and have been shown to be safe for use in general anesthesia. The investigators hope can understand the effects of remimazolam and propofol for general anesthesia on rhythm status and cognitive function through this study, further reduce the occurrence of postoperative cognitive function impairment, and enable subjects to better recover.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-09.
Trial Details
NCT Number NCT06775366
Lead Sponsor The Second Affiliated Hospital of Chongqing Medical University
Conditions Cognitive Functioning, Propofol, Remimazolam, Circadian Rhythm
Enrollment 174 participants
Start Date 2025-02-24
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-14